Georgia Gov. Nathan Deal on Thursday announced two separate efforts to pursue clinical trials on a cannabis-based drug that has shown promise in helping children who suffer from seizure disorders. The first would pair a private pharmaceutical company with a Georgia Regents University professor and expand ongoing clinical trials of a product using cannabidiol, or CDB, a compound in marijuana that doesn’t produce a high in users.